APPB OTC
Applied Biosciences Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -96.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0002
Volume520
Avg Volume46
Beta-2.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher Michael Bridges
Employees25
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2016-02-09
Websiteappliedbiocorp.com
9701 Wilshire Boulevard
Beverly Hills, CA 90212
US
Beverly Hills, CA 90212
US
310 356 7374
About Applied Biosciences Corp.
Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Beaubaire Michael | 0 | — | 2019-10-03 | |
| Brady John Robert | A-Award | 100,000 | — | 2019-09-13 |
| Urbanski Raymond W. | 0 | — | 2019-05-28 | |
| Urbanski Raymond W. | 0 | $1.23 | 2019-05-28 | |
| Stevens Scott B | 0 | — | 2019-04-15 |